ReviewNature reviews. Rheumatology2021
Key opinion leaders - a critical perspective.
Review in Nature reviews. Rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Endoscopic spine surgery: a bibliometric and citation analysis of the most influential articles and authors across 19 spine journals (1976-2025).European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Review
- Driving emerging technology to clinical impact.Journal of the American Dental Association (1939) · 2026Review
- Barriers and opportunities for clinical trials in Bahrain: a qualitative study of key opinion leaders.BMJ open · 2026Article
- Bridging functional bionanomaterials and the clinic: strategic communication as a translational enabler.Journal of nanobiotechnology · 2026Review
- How big is the medical writing industry? Why it matters.Health promotion international · 2025Article
- As new cell and gene therapies emerge from academia, we must RISE to the opportunity.Nature biotechnology · 2025Article
- Evolution and mitigation strategies of online public opinion: An analysis using an improved replicator dynamic three-party game model.PloS one · 2025Article
- Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents.Exploratory research in clinical and social pharmacy · 2024Review
- Financial conflicts of interest among authors of clinical practice guideline for headache disorders in Japan.BMC medical ethics · 2024Article
- Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan.BMC medical ethics · 2024Article
- Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States.Gynecologic oncology · 2024Article
- Promoting opioids, a story about how to influence medical science and opinions.Frontiers in medicine · 2024Article
- Social media stethoscope: unraveling how doctors' social media behavior affects patient adherence and treatment outcome.Frontiers in public health · 2024Article
- Industry Payments to United States Rheumatologist-Authors of Publications in High-Impact Rheumatology Journals.ACR open rheumatology · 2023Article
- Mental Health Professionals' Attitudes Toward Digital Mental Health Apps and Implications for Adoption in Portugal: Mixed Methods Study.JMIR human factors · 2023Article
- A new uncertain multi-objective programming model with chance-entropy constraint for advertising promotion.Journal of ambient intelligence and humanized computing · 2023Article
- Promotional Payments to Medical Oncologists and Urologists and Prescriptions for Abiraterone and Enzalutamide.Urology · 2022Article
- Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space.Health care analysis : HCA : journal of health philosophy and policy · 2022Article
- Supporting the vital role of boundary-spanning physician researchers in the advancement of medical innovation.Future healthcare journal · 2021Article
- Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond.Current rheumatology reports · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Enormous progress has been made in the field of rheumatology in the past several decades, historically led by publicly funded academic innovators but in more recent times with much greater involvement of the pharmaceutical industry. This shift in resources has created a complex new model for reinvestment in the medical community in which the vast majority of private funds are redirected towards influencing the prescription behaviour of practitioners through 'key opinion leaders', with the main purpose of enhancing and perpetuating profit rather than innovation and critical thinking, and often at the expense of partnerships with scientists (that is, basic and translational researchers) and academic collaborations. This new episteme brings multiple opportunities to rethink approaches to sustaining long-term critical research in the field, ultimately maximizing the return on investment: scientific knowledge for the benefit of patients and society. Central to such strategies should be the rebalancing of academia-industry partnerships towards academic research and the involvement of 'innovation and knowledge leaders', rather than mostly key opinion leaders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.